Correlation Between Therapeutic Solutions and Living Cell
Can any of the company-specific risk be diversified away by investing in both Therapeutic Solutions and Living Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Therapeutic Solutions and Living Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Therapeutic Solutions International and Living Cell Technologies, you can compare the effects of market volatilities on Therapeutic Solutions and Living Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Therapeutic Solutions with a short position of Living Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Therapeutic Solutions and Living Cell.
Diversification Opportunities for Therapeutic Solutions and Living Cell
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Therapeutic and Living is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Therapeutic Solutions Internat and Living Cell Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Living Cell Technologies and Therapeutic Solutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Therapeutic Solutions International are associated (or correlated) with Living Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Living Cell Technologies has no effect on the direction of Therapeutic Solutions i.e., Therapeutic Solutions and Living Cell go up and down completely randomly.
Pair Corralation between Therapeutic Solutions and Living Cell
Given the investment horizon of 90 days Therapeutic Solutions International is expected to under-perform the Living Cell. In addition to that, Therapeutic Solutions is 3.01 times more volatile than Living Cell Technologies. It trades about -0.13 of its total potential returns per unit of risk. Living Cell Technologies is currently generating about 0.21 per unit of volatility. If you would invest 0.43 in Living Cell Technologies on September 12, 2024 and sell it today you would earn a total of 0.08 from holding Living Cell Technologies or generate 18.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Therapeutic Solutions Internat vs. Living Cell Technologies
Performance |
| Timeline |
| Therapeutic Solutions |
| Living Cell Technologies |
Therapeutic Solutions and Living Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Therapeutic Solutions and Living Cell
The main advantage of trading using opposite Therapeutic Solutions and Living Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Therapeutic Solutions position performs unexpectedly, Living Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Living Cell will offset losses from the drop in Living Cell's long position.| Therapeutic Solutions vs. Ensysce Biosciences | Therapeutic Solutions vs. Aptorum Group Ltd | Therapeutic Solutions vs. Regen BioPharma | Therapeutic Solutions vs. Alpha Cognition |
| Living Cell vs. Sino Biopharmaceutical Ltd | Living Cell vs. Defence Therapeutics | Living Cell vs. Aileron Therapeutics | Living Cell vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |